GR3034525T3 - Human and murine interleukin-5 receptor. - Google Patents

Human and murine interleukin-5 receptor.

Info

Publication number
GR3034525T3
GR3034525T3 GR20000402215T GR20000402215T GR3034525T3 GR 3034525 T3 GR3034525 T3 GR 3034525T3 GR 20000402215 T GR20000402215 T GR 20000402215T GR 20000402215 T GR20000402215 T GR 20000402215T GR 3034525 T3 GR3034525 T3 GR 3034525T3
Authority
GR
Greece
Prior art keywords
receptor
interleukin
human
murine
secretory
Prior art date
Application number
GR20000402215T
Other languages
English (en)
Inventor
Kiyoshi Takatsu
Akira Tominaga
Satoshi Takagi
Yoshiyuki Murata
Original Assignee
Kiyoshi Takatsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiyoshi Takatsu filed Critical Kiyoshi Takatsu
Publication of GR3034525T3 publication Critical patent/GR3034525T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR20000402215T 1990-09-11 2000-09-29 Human and murine interleukin-5 receptor. GR3034525T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24063890 1990-09-11

Publications (1)

Publication Number Publication Date
GR3034525T3 true GR3034525T3 (en) 2000-12-29

Family

ID=17062477

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402215T GR3034525T3 (en) 1990-09-11 2000-09-29 Human and murine interleukin-5 receptor.

Country Status (8)

Country Link
US (4) US5453491A (el)
EP (1) EP0475746B1 (el)
JP (1) JP2749730B2 (el)
AT (1) ATE194652T1 (el)
DE (1) DE69132306T2 (el)
DK (1) DK0475746T3 (el)
ES (1) ES2149156T3 (el)
GR (1) GR3034525T3 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW280833B (el) * 1990-12-27 1996-07-11 Hoffmann La Roche
EP0533006A1 (en) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
DE4317577A1 (de) * 1993-05-27 1994-12-01 Boehringer Ingelheim Int Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
US6806061B1 (en) * 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
KR100259828B1 (ko) 1995-09-11 2000-06-15 히라타 다다시 인체 인터루킨 5 수용체 알파-사슬에 대한 항체
US20020090682A1 (en) * 1995-10-23 2002-07-11 Tracy Willson Novel haemopoietin receptor and genetic sequences encoding same
US7074397B1 (en) 1996-01-08 2006-07-11 Genentech, Inc. Method for enhancing proliferation or differentiation of a cell using ob protein
US6541604B1 (en) * 1996-01-08 2003-04-01 Genentech, Inc. Leptin receptor having a WSX motif
US20050019325A1 (en) * 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
JP3423842B2 (ja) * 1996-01-19 2003-07-07 日研化学株式会社 変異株及び該変異株又は親株を用いるエリスリトールの製造方法
US20060205660A1 (en) * 1996-06-20 2006-09-14 Sauvage Frederic D OB protein-immunoglobulin chimeras
US6743604B1 (en) * 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
ES2568899T3 (es) * 1999-04-09 2016-05-05 Kyowa Hakko Kirin Co., Ltd. Procedimiento para controlar la actividad de una molécula inmunofuncional
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
EP2385069A3 (en) 2003-11-12 2012-05-30 Biogen Idec MA Inc. Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
ATE541585T1 (de) * 2004-10-28 2012-02-15 Kyowa Hakko Kirin Co Ltd Antikörper gegen il-5-rezeptor zur verwendung in der behandlung von endometriose.
NZ556788A (en) 2005-01-05 2011-03-31 Biogen Idec Inc Humanized CRIPTO binding molecules with CDRs from murine B3F6
AU2006318580A1 (en) * 2005-11-21 2007-05-31 Merck Serono Sa Compositions and methods of producing hybrid antigen binding molecules and uses thereof
DK2591099T3 (da) 2010-07-09 2021-02-15 Bioverativ Therapeutics Inc Kimære koagulationsfaktorer
US9738707B2 (en) 2011-07-15 2017-08-22 Biogen Ma Inc. Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
CA2860579A1 (en) 2012-01-10 2013-07-18 Biogen Idec Ma Inc. Enhancement of transport of therapeutic molecules across the blood brain barrier
EP2968498A4 (en) 2013-03-15 2016-09-07 Biogen Ma Inc PREPARATIONS CONTAINING FACTOR IX POLYPEPTIDE
ES2904276T3 (es) 2013-09-27 2022-04-04 Massachusetts Inst Technology Nanoestructuras de proteínas biológicamente activas sin vehículo
EP3954993A1 (en) 2015-02-04 2022-02-16 Bristol-Myers Squibb Company Methods of selecting therapeutic molecules
EP3253875B1 (en) 2015-02-04 2020-01-08 H. Hoffnabb-La Roche Ag Tau antisense oligomers and uses thereof
CN108990413A (zh) 2015-08-12 2018-12-11 麻省理工学院 纳米颗粒的细胞表面偶联
CA3029813A1 (en) 2016-06-13 2017-12-21 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
EP3678701A4 (en) 2017-09-05 2021-12-01 Torque Therapeutics, Inc. THERAPEUTIC PROTEIN COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF
AU2022349077A1 (en) * 2021-09-22 2024-03-28 Sonoma Biotherapeutics, Inc. Il5ra cell surface markers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5171840A (en) * 1988-01-22 1992-12-15 Tadamitsu Kishimoto Receptor protein for human B cell stimulatory factor-2
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
CA2007305A1 (en) * 1989-01-09 1990-07-09 Nicole Suciu-Foca Differentiation antigen, nda4, associated with the receptor for b cell growth factor
TW280833B (el) * 1990-12-27 1996-07-11 Hoffmann La Roche

Also Published As

Publication number Publication date
ES2149156T3 (es) 2000-11-01
US5916767A (en) 1999-06-29
US5807991A (en) 1998-09-15
ATE194652T1 (de) 2000-07-15
DE69132306D1 (de) 2000-08-17
DE69132306T2 (de) 2001-03-01
DK0475746T3 (da) 2000-10-30
US5760204A (en) 1998-06-02
JP2749730B2 (ja) 1998-05-13
EP0475746B1 (en) 2000-07-12
EP0475746A1 (en) 1992-03-18
JPH0654690A (ja) 1994-03-01
US5453491A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
GR3034525T3 (en) Human and murine interleukin-5 receptor.
IL92205A0 (en) Portable adjustable child's chair
IL78183A0 (en) Chair with articulated flexible spring backrest
ZA885752B (en) Armchair with supple backrest
EP0477762A3 (en) Reclining chair
NZ241094A (en) Dna encoding the alpha-chain of human interleukin -5 receptor, the protein encoded and its use
DE3480166D1 (en) Armchair with tiltable seat
GB8508231D0 (en) Adjustable reclining chair
GB8716041D0 (en) Adjustable chair
IT8335696V0 (it) Poltrona con spalliera, sedile e poggiapiedi movibili comandati e posizionati dal corpo dell'occupante
IT1232070B (it) Schienale per sedie e simili con regolazione del profilo dell'imbottitura
CA58788S (en) Chair seat unit
IL82301A0 (en) Reclining chairs
AU101247S (en) Child's chair
IT218936Z2 (it) Poltrona a sdraio, in particolare per bambini con dispositivo ad accoppiamento elastico per la regolazione dell'inclinazione dello schienale
AU98722S (en) Recliner chair
GB8726461D0 (en) Chair platform
GB8707504D0 (en) Orthopaedic seats chairs &c
HUT39584A (en) Sitting furniture with footrest that opens respectively inclinable back
AU102024S (en) Rocking chair
GB8707701D0 (en) Chair mirror
PL246643A1 (en) Chair with adjustable seat
PL268886A1 (en) Office chair
AU107098S (en) Chair or stool
IL82819A0 (en) Improved chair

Legal Events

Date Code Title Description
MA Right expired

Effective date: 20110912